% | $
Quotes you view appear here for quick access.

aTyr Pharma Inc. Message Board

  • ham1198 ham1198 Jun 10, 2011 4:56 PM Flag

    S&P Recommendation STRONG BUY

    Analysis prepared by Equity Analyst Jeffrey Loo CFA on May 12, 2011, when the stock traded at $55.88

    "We expect sales to rise 6.5% in 2011 to $3.8 billion.
    We look for sales in molecular biology,
    driven by robust demand for genomic assays
    and real-time PCR consumables, to rise in the
    mid single-digits; genetic systems, aided by
    strong sales from the introduction of its Ion Torrent
    Personal Genome Machine and from the
    new SOLiD 5500xl, to grow in the high singledigits;
    and Cell System sales, on robust primary
    stem cell sales, to rise in the high single-digits.
    Due to currency hedges, we see gross margins
    declining 20 basis points (bps), but we forecast
    operating margins will rise 60 bps on leverage
    and cost saving synergies. Increased usage of
    LIFE's eCommerce platform, which currently
    processes 55% of transactions, should also
    boost margins".

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.90-0.08(-2.68%)Aug 29 4:00 PMEDT